CRISPR Plus Drug Treatment Makes Neuroblastoma Responsive to Immunotherapy
Researchers in Italy and Australia report a triple combination strategy involving CRISPR that boosts the response of neuroblastoma to immunotherapy.
Researchers in Italy and Australia report a triple combination strategy involving CRISPR that boosts the response of neuroblastoma to immunotherapy.
Tags:
Comments